35 Fase- III kliniske forsøg Der er gennemført 2 randomiserede, åbne forsøg for at evaluere effekten af dasatinib, administreret 1 gang dagligt sammenlignet med dasatinib, administreret 2 gange dagligt:
Phase III Clinical Trials Two randomised, open-label studies were conducted to evaluate the efficacy of dasatinib administered once daily compared with dasatinib administered twice daily: